切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2022, Vol. 11 ›› Issue (01) : 18 -23. doi: 10.3877/cma.j.issn.2095-3224.2022.01.003

专家论坛

国内外结直肠癌筛查的对比分析及启示
刘正1, 王锡山1,()   
  1. 1. 100021 北京,国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医院肿瘤医院结直肠外科
  • 收稿日期:2021-12-26 出版日期:2022-02-25
  • 通信作者: 王锡山
  • 基金资助:
    中国医学科学院中央级公益性科研院所基本科研业务费(2021-RC310-009)

Comparative analysis and inspiration of colorectal cancer screening at China and abroad

Zheng Liu1, Xishan Wang1,()   

  1. 1. Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • Received:2021-12-26 Published:2022-02-25
  • Corresponding author: Xishan Wang
引用本文:

刘正, 王锡山. 国内外结直肠癌筛查的对比分析及启示[J/OL]. 中华结直肠疾病电子杂志, 2022, 11(01): 18-23.

Zheng Liu, Xishan Wang. Comparative analysis and inspiration of colorectal cancer screening at China and abroad[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2022, 11(01): 18-23.

我国结直肠癌的发病率和死亡率在逐年升高,严重威胁人民群众的健康,亟待采取行之有效并且适合我国国情的结直肠癌筛查策略,从而降低结直肠癌的疾病负担。目前面临的突出问题是,我国人群结直肠癌筛查项目覆盖尚不广泛,方法并不统一,有待形成完善的国家结直肠癌筛查体系。建立筛查体系的作用在于发现癌前病变和早期病例,从而降低发病率并提高早期病例构成比,具有很重要的卫生经济学意义。本文结合国内外最新指南共识,阐述国内外结直肠癌筛查的历程和现状,比较了结直肠癌筛查常用的方法,并对我国筛查的发展提出了展望,以期未来能够建立具有我国特色的结直肠癌筛查策略。

The incidence and death rate of colorectal cancer has shown an upward trend in China. Colorectal cancer turns to be a great threat to people's health. There is an urgent need for my country to adopt an effective and suitable colorectal cancer screening strategy to reduce the disease burden of colorectal cancer. The prominent problem currently faced is that the coverage of colorectal cancer screening programs for the population in my country is not yet extensive, and the methods are not uniform. A comprehensive national colorectal cancer screening system needs to be formed. The role of establishing a screening system is to detect precancerous lesions and early cases, thereby reducing the incidence and increasing the proportion of early cases, which is of great significance in health economics. This article briefly descirbed the development and current status of colorectal cancer screening international, comparaed several frequently used methods, introduced the latest guidelines and consensus of colorectal cancer screening, and put forward ideas and suggestions for the establishment of colorectal cancer screening system in China.

[1]
Ferlay JEM, Lam F, Colombet M, et al. Global cancer observatory: cancer today. Lyon, france: international agency for research on cancer.[EB/OL].(2020-03-02)[2021-08-27].

URL    
[2]
Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020[J]. CA: A Cancer Journal for Clinicians, 2020, 70(3): 145-164.
[3]
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28.
[4]
National Cancer Institute. Cancer Stat Facts: Colorectal Cancer[EB/OL].(2017-02-07) [2021-08-27].

URL    
[5]
Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies[J]. Bmj, 2014, 348: g2467.
[6]
NdPilonis, Bugajski M, Wieszczy P, et al. Long-term colorectal cancer incidence and mortality after a single negative screening colonoscopy [J]. Ann Intern Med, 2020, 173(2): 81-91.
[7]
Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer[J]. N Engl J Med, 2013, 369(12): 1106-1114.
[8]
CHIU HM, CHEN SL, YEN AM, et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program[J]. Cancer, 2015, 121(18): 3221-3229.
[9]
Lin JS, Perdue LA, Henrikson NB, et al. Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force[J]. JAMA, 2021, 325(19): 1978-1997.
[10]
王红, 黄慧瑶, 刘成成, 等. 我国结直肠癌筛查卫生经济学证据系统更新:2009-2018[J]. 中华流行病学杂志, 2020, 41(3): 429-435.
[11]
健康中国行动推进委员会. 健康中国行动(2019-2030年)[EB/OL].(2019-07-15)[2021-08-27].

URL    
[12]
Guo F, De Brabander I, Francart J, et al. Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme[J]. Br J Cancer, 2020, 122(7): 1109-1117.
[13]
Vart G, Banzi R, Minozzi S. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis[J]. Prev Med, 2012, 55(2): 87-92.
[14]
Tinmouth J, Lansdorp-vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know[J]. Gut, 2015, 64(8): 1327-1337.
[15]
国家癌症中心中国结直肠癌筛查与早诊早治指南制定专家组. 中国结直肠癌筛查与早诊早治指南(2020,北京)[J]. 中华肿瘤杂志, 2021, 43(1): 16-38.
[16]
Allison JE, Fraser CG, Halloran SP, et al. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT)[J]. Gut Liver, 2014, 8(2): 117-130.
[17]
Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening[J]. N Engl J Med, 2014, 370(14): 1287-1297.
[18]
关旭, 马晨曦, 王炜, 等. 多靶点粪便FIT-DNA检测技术在结直肠癌患者、配偶及一级亲属筛查中的应用研究[J/OL]. 中华结直肠疾病电子杂志, 2021, 10(3): 237-242.
[19]
Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy[J]. N Engl J Med, 2012, 366(25): 2345-2357.
[20]
U.S. Centers for Disease Control and Prevention. Colorectal Cancer Statistics[EB/OL]. (2021-07-08) [2021-08-27].

URL    
[21]
Cancer Research UK. Bowel Cancer Screening Coverage and Uptake, UK, FY2012-2015[EB/OL].(2021-07-31) [2021-08-27].

URL    
[22]
Singh H, Bernstein CN, Samadder JN, et al. Screening rates for colorectal cancer in Canada: a cross-sectional study[J]. CMAJ Open, 2015, 3(2): E149-157.
[23]
Australian Institute of Health and Welfare. Bowel cancer screening in Australia[EB/OL].(2020-07-31) [2021-08-27].

URL    
[24]
厚生労働省. 2019年国民生活基礎調査の概況[EB/OL].(2010-07-17) [2021-08-27].

URL    
[25]
Hong S, Lee YY, Lee J, et al. Trends in cancer screening rates among korean men and women: results of the Korean national cancer screening survey, 2004—2018[J]. Cancer Res Treat, 2021, 53(2): 330-338.
[26]
衛生福利部國民健康署. 102年50-69歲民眾最近兩年內接受大腸癌篩檢率[EB/OL].(2016-04-15)[2021-08-27].

URL    
[27]
高乐, 于树青, 杨继春, 等. 全球结直肠癌筛查指南的质量评价[J]. 北京大学学报(医学版), 2019, 51(3): 176-183.
[28]
田剑波, 温艳, 杨卓煜, 等. 全球结直肠癌筛查指南及共识质量评价[J]. 中华流行病学杂志, 2021, 42(2): 248-257.
[29]
Davidson KW, Barry MJ, Mangione CM, et al. Screening for colorectal cancer: US preventive services task force recommendation statement [J]. JAMA, 2021, 325(19): 1965-1977.
[30]
Shaukat A, Kahi CJ, Burke CA, et al. ACG Clinical Guidelines: Colorectal Cancer Screening 2021[J]. Am J Gastroenterol, 2021, 116(3): 458-479.
[31]
吴春晓, 顾凯, 龚杨明, 等. 2015年中国结直肠癌发病和死亡情况分析[J]. 中国癌症杂志, 2020, 30(4): 241-245.
[32]
Zheng GM, Choi BC, Yu XR, et al. Mass screening for rectal neoplasm in Jiashan County, China[J]. J Clin Epidemiol, 1991, 44(12): 1379-1385.
[33]
杨金华, 沈飞琼, 薛峰, 等. 2007-2016年浙江省嘉善县结直肠癌筛查方案应用评价[J]. 中国肿瘤, 2020, 29(12): 919-924.
[34]
陈万青, 李霓, 曹毛毛, 等. 2013-2017年中国城市癌症早诊早治项目基线结果分析[J]. 中国肿瘤, 2020, 29(1): 1-6.
[35]
陈宏达, 李霓, 任建松, 等. 中国城市结直肠癌高危人群的结肠镜筛查依从性及其相关因素分析[J]. 中华预防医学杂志, 2018, 52(3): 231-237.
[36]
安锦慧, 孙治平, 李云涛, 等. 我国结直肠癌筛查的影响因素文献分析及思考[J]. 中国全科医学, 2020, 23(23): 2877-2882.
[37]
国家消化系统疾病临床医学研究中心(上海), 国家消化道早癌防治中心联盟, 中华医学会消化内镜学分会, 等. 中国早期结直肠癌筛查流程专家共识意见(2019, 上海)[J]. 中华医学杂志, 2019, 99 (38): 2961-2970.
[38]
王锡山. 中美结直肠癌流行病学特征及防诊治策略的对比分析[J/OL]. 中华结直肠疾病电子杂志, 2017, 6(6): 447-453.
[39]
张愉涵, 陈宏达, 卢明, 等. 结直肠癌筛查和早期诊断生物标志物研究进展[J]. 中华流行病学杂志, 2021, 42(1): 142-148.
[40]
Tepus M, Yau TO. Non-Invasive Colorectal Cancer Screening: An Overview[J]. Gastrointest Tumors, 2020, 7(3): 62-73.
[41]
胡茜玥, 刘正, 王锡山. 结直肠癌筛查策略的研究现状与思考[J]. 中国全科医学, 2021, 24(33): 4165-4171.
[1] 顾莉莉, 姜凡. 安徽省超声产前筛查切面图像质量现状调查情况及分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 671-674.
[2] 明昊, 肖迎聪, 巨艳, 宋宏萍. 乳腺癌风险预测模型的研究现状[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 287-291.
[3] 钱警语, 郑明明. 《2024意大利妇产科学会非侵入性和侵入性产前诊断指南》解读[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 486-492.
[4] 罗青杉, 梅海涛, 郝家领, 蔡锦锋, 周润楷, 温玉刚. 连接蛋白43通过调控细胞周期抑制结直肠癌的增殖机制研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 344-349.
[5] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[6] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[7] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[8] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[9] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[10] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[11] 张蔚林, 王哲学, 白峻阁, 黄忠诚, 肖志刚. 利用TCGA数据库构建基于miRNA的结直肠癌列线图预后模型[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 381-388.
[12] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
[13] 任佳琪, 刁德昌, 何自衍, 张雪阳, 唐新, 李文娟, 李洪明, 卢新泉, 易小江. 网膜融合线导向的脾曲游离技术在左半结肠癌根治术中的应用[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 362-367.
[14] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[15] 杨钲, 彭鑫鑫, 王响, 李俊杰, 巩承舜, 宋光彩. 健康中国战略背景下四川省西昌市居民日本血吸虫病防治知识及态度行为研究[J/OL]. 中华临床实验室管理电子杂志, 2024, 12(04): 221-228.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?